Tsuyoshi Uehara

ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Venues

Microbiology spectrum

ACS infectious diseases

PloS one

Journal of the American Chemical Society

VenatoRx Pharmaceuticals (United States)

Tokyo Daigaku (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VenatoRx Pharmaceuticals (United States) Dec 3o 2018

United States

Principal Scientist

Education History

Tokyo Daigaku Apr 1o 1997 - Mar 31o 2000

Japan

PHD :: Biotechnology

Publications

Elyse J Roach, Tsuyoshi Uehara, Denis M Daigle, David A Six, Cezar M Khursigara
The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli. Microbiology spectrum 9 (2) (2021)
Wooseok Han, Xiaolei Ma, Carl J Balibar, Christopher M Baxter Rath, Bret Benton, Alun Bermingham, Fergal Casey, Barbara Chie-Leon, Min-Kyu Cho, Andreas O Frank, Alexandra Frommlet, Chi-Min Ho, Patrick S Lee, Min Li, Andreas Lingel, Sylvia Ma, Hanne Merritt, Elizabeth Ornelas, Gianfranco De Pascale, Ramadevi Prathapam, Katherine R Prosen, Dita Rasper, Alexey Ruzin, William S Sawyer, Jacob Shaul, Xiaoyu Shen, Steven Shia, Micah Steffek, Sharadha Subramanian, Jason Vo, Feng Wang, Charles Wartchow, Tsuyoshi Uehara
Two Distinct Mechanisms of Inhibition of LpxA Acyltransferase Essential for Lipopolysaccharide Biosynthesis. Journal of the American Chemical Society 142 (9) (2020)
Xiaolei Ma, Ramadevi Prathapam, Charles Wartchow, Barbara Chie-Leon, Chi-Min Ho, Javier De Vicente, Wooseok Han, Min Li, Yipin Lu, Savithri Ramurthy, Steven Shia, Micah Steffek, Tsuyoshi Uehara
Structural and Biological Basis of Small Molecule Inhibition of Escherichia coli LpxD Acyltransferase Essential for Lipopolysaccharide Biosynthesis. ACS infectious diseases 6 (6) (2019)
William S Sawyer, Lisha Wang, Tsuyoshi Uehara, Pramila Tamrakar, Ramadevi Prathapam, Mina Mostafavi, Louis E Metzger, Brian Feng, Christopher M Baxter Rath
Targeted lipopolysaccharide biosynthetic intermediate analysis with normal-phase liquid chromatography mass spectrometry. PloS one 14 (2) (2019)

Tsuyoshi Uehara.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tsuyoshi Uehara